PLoS ONE (Jan 2021)

Clinical and whole genome characterization of SARS-CoV-2 in India.

  • Radhakrishna Muttineni,
  • Nagamani Kammili,
  • Thrilok Chander Bingi,
  • Raja Rao M,
  • Kalyani Putty,
  • Pankaj Singh Dholaniya,
  • Ravi Kumar Puli,
  • Sunitha Pakalapati,
  • Saritha S,
  • Shekar K,
  • Mallikarjuna Reddy Doodipala,
  • Amit A Upadhyay,
  • Steven E Bosinger,
  • Rama R Amara,
  • Anand K Kondapi

DOI
https://doi.org/10.1371/journal.pone.0246173
Journal volume & issue
Vol. 16, no. 2
p. e0246173

Abstract

Read online

We report clinical profile of hundred and nine patients with SARS CoV-2 infection, and whole genome sequences (WGS) of seven virus isolates from the first reported cases in India, with various international travel histories. Comorbidities such as diabetes, hypertension, and cardiovascular disease were frequently associated with severity of the disease. WBC and neutrophil counts showed an increase, while lymphocyte counts decreased in patients with severe infection suggesting a possible neutrophil mediated organ damage, while immune activity may be diminished with decrease in lymphocytes leading to disease severity. Increase in SGOT, SGPT and blood urea suggests the functional deficiencies of liver, heart, and kidney in patients who succumbed to the disease when compared to the group of recovered patients. The WGS analysis showed that these isolates were classified into two clades: I/A3i, and A2a (four according to GISAID: O, L, GR, and GH). Further, WGS phylogeny and travel history together indicate possible transmission from Middle East and Europe. Three S protein variants: Wuhan reference, D614G, and Y28H were identified predicted to possess different binding affinities to host ACE2.